Contact Us Donate Now
Home / Conferences and Events / Miami Thyroid Oncology Symposium

The 7th Annual Miami Thyroid Oncology Symposium will be held on Friday February 28th, and Saturday March 1st, 2025

About the Symposium

We welcome you to the 7th Annual Miami Thyroid Oncology Symposium to discuss the rapidly expanding science of "Thyroid Oncology". The science of thyroid cancer diagnosis and treatment is rapidly evolving. The new paradigm involving molecular pathology and nuclear theranostics have profoundly changed the philosophy and techniques of surgery and radioactive iodine (RAI) beta-knife therapy.

Genomic and epigenomic molecular profiling have become an integrated part of cytologic evaluation of nodular thyroid disease, diagnosis and risk stratification in thyroid cancer. The traditional characterization of tumor differentiation/de-differentiation for the purposes of clinical prognostic assessments and more importantly definition/redefinition of the role of RAI treatment for individual cancer phenotypes are now being expressed by molecular characteristics. Risk stratification systems are evolving towards a theranostic model that will critically guide the initial surgical treatment and subsequent use of radioactive iodine.

The Miami Thyroid Oncology Symposium offers a platform for in depth discussions of the science of thyroid cancer diagnosis and treatment in this new paradigm. It is a unique scientific forum where practicing physicians learn how to adopt and incorporate the new diagnostic and treatment tools and techniques into their  daily practice.

The symposium is a two-day program. The first day of the symposium on Friday February 28, 2025, what we traditionally refer as “Frontiers in Thyroid Oncology” session, brings together world renowned experts presenting and discussing the state of the art in Thyroid cancer diagnosis and treatment. The focus of this session is Molecular Diagnostics and Molecular Therapeutics. The second day of the symposium on Saturday, March 1, 2025, will focus on advances in Radioactive iodine (RAI) Theranostics, which will provide an in-depth overview of RAI theranostics and address the equipoise on RAI imaging, and therapy. The session focuses on the radiobiology and dosimetry of RAI, as it links to genomics-transcriptomics-proteomics-metabolomics chain. 

The MTOS 2025  is a hybrid event. Symposium will be held at the Roz & Cal Kovens Center at FIU’s Biscayne Campus. The event will be live broadcasted for national and international audience. The core faculty will be attending in person. The symposium welcomes all professionals involved or panel debates and Q&A. Technical topics will include video presentations as well.

We are committed to uphold the high-quality symposium standards we have built in the prior years. We are indebted to our world-renowned faculty for taking part in this exciting new scientific platform. We also hope to expand our attendance by reaching a larger national and international audience via the hybrid format.

Event Program

Event Program

Registration

Registration

[image]
Symposium Sponsors

Symposium Sponsors